About 454,000 results
Open links in new tab
  1. Your Guide to Yorvipath for Hypoparathyroidism - WebMD

    Feb 13, 2025 · Your health care provider will do a blood test to check the amount of calcium and vitamin D in your blood before you start Yorvipath.

  2. Yorvipath for Hypoparathyroidism - HealthCentral

    Jan 29, 2025 · How Does Yorvipath Work to Treat Hypoparathyroidism? Normally, parathyroid hormone (PTH) slows down bone-building cells and speeds up bone-breaking cells, leading to bone …

  3. Palopegteriparatide (YORVIPATH) in Hypoparathyroidism National Drug Mini-monograph June 2025 VA Pharmacy Benefits Management Services and National Formulary Committee The purpose of VA …

  4. Your health care provider should check your blood calcium before you start and during your treatment with YORVIPATH. Tell your health care provider if you have nausea, vomiting, dizziness, feeling …

  5. Yorvipath: Uses, Dosage, Side Effects, Warnings - Drugs.com

    Aug 13, 2024 · Uses Side effects Before taking Directions Dosage Interactions What is Yorvipath? Yorvipath (palopegteriparatide) is an injectable parathyroid hormone replacement therapy that can …

  6. As stated in the prescribing information, the prescriber should confirm 25-hydroxyvitamin D stores are within the normal range and serum calcium is above 7.8 mg/dL before starting Yorvipath.

  7. Yorvipath: Dosage, side effects, price, uses, and more

    Mar 14, 2025 · Yorvipath (palopegteriparatide) is a prescription injection that treats hypoparathyroidism in adults, Learn about dosage, side effects, cost, uses, and more.

  8. Yorvipath for hypoparathyroidismHypoparathyroidism News

    Aug 19, 2024 · By providing a round-the-clock supply of PTH, Yorvipath aims to increase blood calcium levels and ease hypoparathyroidism symptoms without the need for vitamin D supplements or …

  9. These highlights do not include all the information needed to use ...

    The phase 3 trial included 82 subjects with hypoparathyroidism with a median YORVIPATH treatment duration of 182 days (Study 1) [see Clinical Studies (14)]. Adverse reactions associated with …

  10. Yorvipath (Palopegteriparatide Injection, for Subcutaneous Use): Side ...

    Aug 28, 2024 · What Is Yorvipath? Yorvipath (palopegteriparatide) is a parathyroid hormone analog (PTH (1-34)) indicated for the treatment of hypoparathyroidism in adults. What Are Side Effects of …